The abnormal expression of KIAA1199 has also been found in other cancer studies, such as oral squamous cell carcinoma (Chanthammachat et al., 2013), breast cancer (Evensen et al., 2013), gastric cancer (Matsuzaki et al., 2009), colorectal tumors (Tiwari et al., 2013; Birkenkamp-Demtroder et al., 2011; LaPointe et al., 2012), prostate cancer (Michishita et al., 2006), ovarian cancer (Shen et al., 2019) and hepatocellular carcinoma (Jiang et al., 2018). Here, CEMIP is linked to prostate cancer.